chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had one Moderna shot a couple of months ago and didn't get second one; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jul-2021 and was forwarded to Moderna on 23-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (had one Moderna shot a couple of months ago and didn't get second one) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (had one Moderna shot a couple of months ago and didn't get second one). At the time of the report, PRODUCT DOSE OMISSION ISSUE (had one Moderna shot a couple of months ago and didn't get second one) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   Reporter did not allow further contact
Information was received on 19-APR-2017 from an attorney in the from of an initial legal complaint regarding a female patient (age not reported). Medical history, concurrent condition and concomitant therapy were not reported. On 02-NOV-2012 the patient was vaccinated with ZOSTAVAX (dose not reported) as recommended for routine adult health maintenance for the prevent of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 23-MAY-2016 the patient was treated at a physician's office for an ongoing painful rash and persistent nerve pain which was then diagnosed as a shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical treatment. As a further proximate result the patient suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Information has been received from a pharmacist concerning a 69 year old patient of unknown gender who on 16-SEP-2013 was vaccinated with a 0.5 ml dose of PNEUMOVAX23 lot # 672074/1502AA, Exp date 19-MAY-2013, intramuscular. No adverse effects reported. This is one of several reports received from the same source. Cases linked: 1310USA008719 and 1309USA009508. Additional information has been requested.
COULD NOT SLEEP; like caffeine overload but no rapid heart beat, excessive urination all night,  muscle pain and some sweating when changing position
Pain in leg, parasthesia, neuropathy starting approximately one hour after injection. Health care provider recommended ER/urgent care for possible blot clots.  Neuropathy symptoms ongoing to date.
Patient is a 24 y.o. male with no significant past medical history who presented on 6/25/21 with intermittent headaches. Patient states he was in his normal state of health but after receiving the COVID-19 vaccination on May 1, he developed a headache shortly after and since then has been having worsening headaches with associated sinus congestion. CT head was done at that time which showed some sinusitis. His headache worsened since then prompting evaluation at an outlying facility. Further evaluation at that facility revealed venous sinus thrombosis on CT head and patient was subsequently started on full dose Lovenox and transferred to ED. MRI brain here also revealed thrombosis of dural venous sinuses. Patient was admitted to the ICU for close neurologic monitoring. He was evaluated by neurology.  In the ICU patient remained medically stable.  He was deemed stable for non-ICU level of care and transferred to the hospitalist to continue care.  Heme-onc was consulted.  Patient was evaluated by heme-onc and recommended transitioning to Eliquis and discontinue Lovenox to avoid the possibility of having a HIT type of reaction.  Hypercoagulable work-up was initiated hematology recommended Eliquis for 3 months and to follow-up with a local hematologist for discharge follow-up.  Patient was cleared for discharge from neurology and hematology standpoint.  Patient symptom was controlled on tramadol and Zofran.  It was felt patient received maximum benefit of hospitalization and deemed medically stable for discharge.  Patient was seen contact his primary care physician who states he will enter the referral to hematologist.  Return precautions was discussed with patient and his wife.
pt recvd measles vax on 13JAN92 & following vax devel sl pain & swelling which persisted; On 19JAN92 exp inc pain & swelling w/ 6 cm muscle swelling & induration; there was no erythema;
Over-sleeping on 1/7/21.  Fell asleep @ 5 pm 1/7/21 and slept until 10 am 1/8/21 Insomnia 1/8, 1/9, 1/10 - average 2-4 hours each night Fever of 100.3 on 1/11 from 12 pm till 5 pm
high pitched screaming began approx 1/2hr p/vax & cont until approx 9PM in evening;temp rose to 102;devel significant area of redness, hardness & swelling of rt thigh which lasted for approx 2 days;vomiting w/screaming also;
5hr p/vax pt awakened from nap w/inconsolable crying & local redness/swelling knee to thigh area;APAP had been given 10min a//call to the office;
Spit up; This case was reported by a nurse via call center representative and described the occurrence of regurgitation in a patient who received Rota (Rotarix) for prophylaxis.   On an unknown date, the patient received Rotarix (oral). On an unknown date, immediately after receiving Rotarix, the patient experienced regurgitation. On an unknown date, the outcome of the regurgitation was recovered/resolved.   It was unknown if the reporter considered the regurgitation to be related to Rotarix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient spit up vaccine during administration. No additional details were provided. The reporter stated that no details were provided when requested.
pt recv vax 25OCT95 & 30OCT95 devel double vision & paralysis of the 4th cranial nerve;tx w/pred burst & as of 27NOV95 pt sx were improved;still has a little diff w/quick focusing;
Arm swelling elbow to shoulder 1-2d after tender, tightness worsening pain. Treatment: BENADRYL, AUGMENTIN.
The next morning (exact time was estimated) patient complained he didn't feel good. His symptoms increased to the point of his believing he has Covid again (with the exception of taste and smell); ie: restlessness; fever (off and on); extreme fatigue; coughing; labored breathing; loss of appetite; and difficulty sleeping. He already had Covid-19 and was hospilized over a week and returned home with oxygen and at-home treatment.
Started to feel weak, like she was going to pass out and her heart was pounding.  Went to lay down and felt very cold.  Had 2 layers of clothes on and started to shake.  She looked in the mirror and noticed her lips were blue.  Also noted having trouble talking, only able to answer with one-word responses. Temp 99. - went to ER in HIllsdale where on arrival her temp was 101.6, accompanied by a "terrible" migraine.
On Monday 02/01/21 she developed red swelling and itching over top of her left foot, this cleared up. On Saturday, 02/06/21, she developed 3 red circular itchy spots on her left arm.
Demylinated peripheral neuropathy treatment: IV IGG, Lyrica, Ultracet  2/5/08 Reveiwed only EMG & lab reports from hospital.  EMG report states pt dx w/demyelinating neuropathy, improved w/IVIG but continued to have residual numbness of feet & fingers.  T/C to med recs to request complete med recs. 2/22/08 Received only EMG/NCS dated 12/28/2006 which was abnormal & indicative of an acquired demyelinating sensory motor polyneuropathy c/w GBS; however, early CIDP could not be excluded.  Pt w/ 4 wk hx of progressive numbness of feet & hands w/weakness starting 2 wks s/p flu vax.  Neuro exam on 12/28/06 revealed left hip flexor weakness, DTRs 1+ in arms & absent in legs & sensory gradient to pin prick at knee level.  T/C to med recs to check status of complete med recs as requested.  4/8/08 Reviewed PCP medical records which were just the neurologist reports of 12/22/2006-1/5/2007. FINAL DX: acute demyelinating neuropathy, probable GBS. Patient had developed subacute progressive tingling in hands/feet & difficulty w/fine motor movements with significant discomfort.  Exam of 12/22/07 revealed LUE weakness, slight LE weakness, LE absent reflexes, LE & hands diminished sensation, wide based guarded gait.  Referred for labs, LP & EMG/NCS.  Developed severe positional headache.  Referred for IVIG x 5 days. Per 60 day follow up: Permanent nerve damage in lower legs, ankles, feet, (both legs), arms, elbows, wrists and hands. Loss of feeling numbness, tingling, burning, pain.
Pfizer Vaccine lot #FF8841 was affected due to out of temperature range. No adverse reactions from patients.  194 patient's affected.
2-day history of ringing in his ears, spikes of pain throughout his body, and dizziness; did not require treatment and symptoms resolved, has not had any additional symptoms.
Abdominal cramps, diarrhea and nausea and vomiting. PMD has advised against a 3rd HBV.
Two hours after having my second shot, my face became very tight and felt like it was burning. I had a reddish rash on my face, which gradually went away after about 6 hours. I put a wet, cold cloth on my face, which helped the burning feeling.
The day after vaccination, her "injection" arm became red/swollen/painful.  It lasted about a week.  She did not seek treatment for it.  She took aleve at home.  Note, she had Fluad the same day in the same arm, however, she has had Fluad before without issue.
Soreness of left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of left arm) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of left arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 27-Mar-2021, PAIN IN EXTREMITY (Soreness of left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Itchy, swollen, red induration at injection site (10mm x 40mm)
Low grade fever, chills, profuse sweating swelling at injection site, redness at injection site & tenderness & warmth at injection site. The initial injection of SHINGRIX I did not have any problem except some swelling and redness at injection site and it was a little warm. The fever & chills & sweating lasted from Friday around 9:P.M. until Sunday morning.
Patient was given a Proquad vaccine which contains Varicella and an additional Varicella vaccine at the same time.
Pt received first Heplisav-B on 9/29/2021, and was to receive the second Heplisav-B on 10/28/2021, but received Engerix-B instead.  Pharmacy noted inventory discrepancy 02/24/2022 and review previous consent forms for Heplisav-B to discover the event.  2/24/2022 Pharmacist contacted patient to explain and recommended third Engerix-B to complete the series as recommended per guidelines.  Pharmacist offered to schedule appointment for patient to receive, which she will be in for soon.
I got a blood clot in my varicose vein in my left leg; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), on an unspecified date at single dose for covid-19 immunisation. The patient medical history included varicose vein in the left leg. Concomitant medications were not reported. On an unspecified date in Apr2021, the patient developed a blood clot in the varicose vein in the left leg. Patient clarified that after talking to the doctor patient thought may had the adverse reaction to the first vaccine. Patient was supposed to get Pfizer Vaccine at the day of reporting but when talk to doctor and the urgent care where  was supposed to be getting it, rescheduled it for 04May2021 because 3 days before (in Apr2021) patient got a blood clot in varicose vein in left leg so, they didn't want to go and get the vaccine and rescheduled it for 04May2021. Patient asked if he/she should even get the second vaccine.The final outcome of the event was unknown. Information on the lot/batch number has been requested
Large red lumps and pain and soreness upon touch at injection site. Both left and right thighs have these lumps and my son won't even let us touch them they hurt so bad.
I was hospitalized for loss of vision to left eye. It was diagnosed as a stroke to the eye.
Maculopapular eruption; whole body (knee, elbow and ankle) effusions with erythematous rash. Flu-like syndrome.
Pt came in today (11/6/12) and explained she thinks she got a rxn from shingles vaccine. She received vaccine on 8/29/12 and for 6 weeks after her back was reg & "Burned up". Went to md office (for another problem) and asked about rxn but md did not do anything.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 30-NOV-2018, the patient was vaccinated with expired dose of VAQTA (dose, units and frequency unknown) (lot # N028743 and expiration date 23-NOV-2018). No symptoms were reported. No product quality issue (PQC) was present. This is one of the several reports received from same reporter.
Severe swelling of the gland in the left side of the neck, severe sore throat on the left side only, severe headaches, & fatigue that occurred 3-9 days after the injection.
Received Tdap Monday. Tuesday mild redness and by Wednesday it was larger. Area of redness increased an was warm to the touch. Some soreness. 12.5x7 Erythema, 4.5x3 cm induration. MOTRIN and BENADRYL w/warm compresses.
This itchiness is not comfortable, she cannot function correctly.; different types of stuff coming out of her skin/it's ugly; shortness of breath; chest pain; rash; lack of drug effect; severe itching that started in her arm only but has spread to the entire body/itching is making her extremely miserable; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (severe itching that started in her arm only but has spread to the entire body/itching is making her extremely miserable), DISCOMFORT (This itchiness is not comfortable, she cannot function correctly.), SKIN DISCHARGE (different types of stuff coming out of her skin/it's ugly), DYSPNOEA (shortness of breath) and CHEST PAIN (chest pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included INSULIN, METFORMIN, TORASEMIDE (TORSEMIDE), BISOPROLOL, ASPIRIN [ACETYLSALICYLIC ACID], CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]), GABAPENTIN, LOSARTAN, ROSUVASTATIN, EZETIMIBE and LORATADINE for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (severe itching that started in her arm only but has spread to the entire body/itching is making her extremely miserable). On an unknown date, the patient experienced DISCOMFORT (This itchiness is not comfortable, she cannot function correctly.), SKIN DISCHARGE (different types of stuff coming out of her skin/it's ugly), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), RASH (rash) and DRUG INEFFECTIVE (lack of drug effect). The patient was treated with TRIAMCINOLONE ACETONIDE for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (severe itching that started in her arm only but has spread to the entire body/itching is making her extremely miserable), DISCOMFORT (This itchiness is not comfortable, she cannot function correctly.), SKIN DISCHARGE (different types of stuff coming out of her skin/it's ugly), DYSPNOEA (shortness of breath), CHEST PAIN (chest pain), RASH (rash) and DRUG INEFFECTIVE (lack of drug effect) outcome was unknown.            Patient lab data includes blood test. Patient went to dermatologist but they are treating this topically and patient felt this is not topical but internal. Concomitant over the counter medication unspecified was taken by patient. Treatment information was not provided.
CHILD IS SHOWING REDNESS AT THE SIGHTS  AND WARM TO TOUCH. PT ALSO IS HAVING  SORENESS IN BOTH ARMS
Patient received the PNEUMOVAX 23 vaccination on 7/17/17. Per patient, about 30 minutes after receiving vaccine she had a fever of 103 degrees, swelling, pain, and redness at injection site (right deltoid), which migrated down to right bicep area, around the back of patient's arm and across the right side of patient's chest, muscle and joint aches. Patient did not report her symptoms until 7/20/17. At time of reporting, patient had some redness and swelling of her right arm and her temperature was 99 degrees.
Mild arm tenderness; This is a spontaneous report from a contactable pharmacist reported that a 49-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), intramuscular on the left arm on 17Dec2020 09:00 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced mild arm tenderness on an unspecified date with outcome of recovered. No treatment received for the reported event.
Arrived with abd pain and urinary retenton post chemo. Found to be COVID + and eventually dx w/ severe sepsis 2/2 COVID-19. Received Vit-c, Zithromax, Cefepime, Vit-d, doxy, Xarelto, zinc, O2. Opted for home hospice and discharged.
Pt. came in for office visit on 11/27/2017 and reported she had pain in her left deltoid region since she received the flu shot 2 weeks prior. I spoke with patient after she saw the Nurse Practitioner and informed her the pain she was describing wasn't the typical pain patients experience from a side effect of the vaccine and I would report to VAERS and someone maybe calling her from VAERS. Pt. returned on 12/5 saying pain was no better shoulder xray performed.
pt recvd vax; 10 days later, exp fever, malaise & neck stiffness; not  subsided;
This morning he woke up with the pain again in his left temple.; His temples felt squeezed in a vice.  It lasted 2 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Apr2021 (Lot number: EWD150, Expiration Date: 31Jul2021) at the age of 68 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARANASAL SINUS DISCOMFORT (non-serious) with onset 01May2021, outcome "recovered" (03May2021), described as "His temples felt squeezed in a vice.  It lasted 2 days."; PAIN (non-serious) with onset 06May2021, outcome "unknown", described as "This morning he woke up with the pain again in his left temple.".  Additional information: Caller stated he was watching his diet these days. This morning he woke up with the pain again in his left temple. It was the pain he had the day after the vaccine. The same as the first time, but not as severe, only on one side. Caller has heard of reports about blood clots and was concerned. Caller stated someone that he had a blood clot in his brain that was causing the pain in his temple. Caller asked was this necessary, if not, he would have to go to the Emergency Department. Caller asked does the pain in the temple 5 days after the vaccine, something to be alarmed about. If he could not have this answered he was going to the Emergency Department. Caller stated he does not want his brain to explode. He does not want to have a stroke.  No follow-up attempts are possible. No further information is expected.
Site: Pain at Injection Site-Severe, Systemic: Vomitting, numbness and tingling in arm radiating to shoulder blade-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe, Additional Details: Pt reported arm pain, severe enough to warrant us to administer her 2 extra strength acetaminophen (500mg each).  Approx 20 min later, she started vomiting.  She seemed alert and oriented, reported pain in her arm, numbness radiating to her shoulder blade. BP was checked at 4:30P 148/98 HR100. Pt had more vomiting after about 5 mins, administered bendadry 25mg 1 tablet, vomiting continued. Called Dr's office, they recommended she proceed to the ER. We called the ambulance to carry her
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent. On 06-JUL-2017, the patient was inadvertently vaccinated with one dose of M-M-R II lot # L024267, expiration date 01-JUL-2017 (dose and route were not reported) for prophylaxis. No adverse effects were reported.
Vaccine expired on 8/31/2022; vaccine administered on 9/2/2022. No known adverse reaction
Patient reported left cheek swelling/itching redness about 1.5-2hr after administration of vaccine. No injection site reaction. Given 50mg PO BENADRYL and elevated in clinic, improvement of symptoms. ZYTREC 10mg PO TID for next 3 days.